lysophosphatidic acid has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamano, F; Ishii, S; Kihara, Y; Masago, K; Nakanishi, H; Shimizu, T; Taguchi, R; Tajima, Y; Yanagida, K | 1 |
| Maluccio, M; Skill, N; Wu, J; Xu, Y; Zhao, Z | 1 |
2 other study(ies) available for lysophosphatidic acid and Experimental Hepatoma
| Article | Year |
|---|---|
Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.
Topics: Animals; Blotting, Western; Calcium; Carcinoma, Hepatocellular; Cell Membrane; Cells, Cultured; Cloning, Molecular; Cyclic AMP; Endothelium, Vascular; GTP-Binding Protein alpha Subunits, G12-G13; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Liver Neoplasms, Experimental; Lysophospholipids; Neuroblastoma; Radioligand Assay; Rats; Receptors, Purinergic P2; Umbilical Veins | 2009 |
Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cell Transformation, Neoplastic; Drug Resistance, Multiple; Liver Neoplasms; Liver Neoplasms, Experimental; Lysophospholipids; Mice; Mice, Knockout; Phosphodiesterase Inhibitors; Phospholipids; Phosphoric Diester Hydrolases; Receptors, Lysosphingolipid; Signal Transduction | 2013 |